Akshay K. Vaishnaw

2013

In 2013, Akshay K. Vaishnaw earned a total compensation of $1.7M as Executive Vice President, Research and Development and Chief Medical Officer at Alnylam Pharmaceuticals, a 44% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$241,875
Option Awards$1,048,375
Salary$450,000
Other$7,596
Total$1,747,846

Vaishnaw received $1M in option awards, accounting for 60% of the total pay in 2013.

Vaishnaw also received $241.9K in non-equity incentive plan, $450K in salary and $7.6K in other compensation.

Rankings

In 2013, Akshay K. Vaishnaw's compensation ranked 4,351st out of 12,286 executives tracked by ExecPay. In other words, Vaishnaw earned more than 64.6% of executives.

ClassificationRankingPercentile
All
4,351
out of 12,286
65th
Division
Manufacturing
1,490
out of 4,612
68th
Major group
Chemicals And Allied Products
423
out of 1,462
71st
Industry group
Drugs
290
out of 1,156
75th
Industry
Pharmaceutical Preparations
234
out of 890
74th
Source: SEC filing on March 17, 2016.

Vaishnaw's colleagues

We found four more compensation records of executives who worked with Akshay K. Vaishnaw at Alnylam Pharmaceuticals in 2013.

2013

John Maraganore

Alnylam Pharmaceuticals

Chief Executive Officer

2013

Barry Greene

Alnylam Pharmaceuticals

Chief Operating Officer

2013

Laurence Reid

Alnylam Pharmaceuticals

Senior Vice President and Chief Business Officer

2013

Michael Mason

Alnylam Pharmaceuticals

Vice President of Finance and Treasurer principal financial officer

News

In-depth

You may also like